海通国际2025年7月金股

Investment Focus - Amazon (AMZN US) is highlighted for its leading position in the cloud industry with a global market share of 30%, benefiting from stable margins and growth in IaaS demand [1] - Meta (META US) shows continuous user growth and improved profitability, with expectations for AI marketing to start yielding results [1] - Alphabet (GOOGL US) is expected to improve margins due to rising IaaS cloud scale and strong self-developed capabilities in AI, although its stock price upside is limited [1] - Meituan (3690 HK) demonstrates strong cash flow and cost advantages, with a significant cash reserve of 115 billion yuan, providing a buffer against competition [1] - Broadcom (AVGO US) is expected to see significant revenue growth from ASIC chips, with projected revenue exceeding $20.5 billion by 2026 [1] - NVIDIA (NVDA US) benefits from improving macro conditions and stable capex expectations, with successful product launches anticipated [1] - Samsung (005930 KS) is positioned well with low valuations and upcoming product releases in the AI sector [1] - Lenovo (992 HK) is expected to achieve record revenue driven by AI server business growth [1] - TSM (2330 TT) maintains high utilization rates in advanced processes, with promising profitability outlooks [1] - MediaTek (2454 TT) is collaborating with Nvidia to enhance its product offerings, with significant revenue growth expected from AI ASICs [1] Internet Sector - Tencent (700 HK) is expected to benefit significantly from AI advancements, with revised revenue and profit forecasts for 2025 [2] - NetEase (NTES US) is seeing growth driven by its online gaming segment, with potential for profits to exceed expectations [2] - New Oriental (EDU US) has a diverse revenue stream and a strong offline presence, with a projected 20% CAGR in profits over the next three years [2] - Futu (FUTU US) anticipates a 11% CAGR in AUM from 2025 to 2027, supported by its low commission model and quality customer service [2] Pharmaceutical Sector - Hansoh Pharmaceutical (3692 HK) is expected to see innovative drug revenue exceed 10 billion yuan by 2025, with a strong pipeline in oncology and other therapeutic areas [3] - WuXi AppTec (603259 CH) is positioned for growth driven by its dual focus on oncology and chronic disease, with strong data from its IBI363 product [3] - Innovent Biologics (1801 HK) is expanding its product portfolio with multiple approvals expected, contributing to significant revenue growth [3] - Zai Lab (9688 HK) is focusing on commercializing its innovative drugs, with a projected revenue of 6 billion yuan in 2025 [3] Consumer Sector - Master Kong (322 HK) is expected to benefit from seasonal demand in beverages, with attractive dividend yields [4] - Budweiser APAC (1876 HK) faces challenges due to management instability and low beer consumption [4] - Midea Group (000333 CH) is benefiting from domestic policy support and strong export performance, with a focus on high dividend yields [4] New Energy Vehicles - Li Auto (2015 HK) is leading in smart driving technology, with strong sales performance and new model releases expected [4] - Tesla (TSLA US) is positioned for growth with advancements in autonomous driving technology and strong demand for its vehicles [4] - Geely (175 HK) is expected to launch multiple key models in 2025, enhancing its competitive position in the market [4] Industrial and Energy Sector - GE Vernova (GEV US) is expected to benefit from infrastructure spending in the US, with strong demand for electrical and intelligent equipment [5] - Siemens Energy (ENR GR) is poised for growth as the construction cycle improves in Europe and North America [5] - Cameco (CCJ US) is seeing increased demand for uranium as global clean energy needs rise [5]